Invasive fungal infections are an increasingly frequent etiology of sepsis in critically ill
patients causing substantial morbidity and mortality. Candida species are by far the …

A substantial proportion of patients become colonised with Candida spp during hospital
stay, but only few subsequently develop severe infection. Clinical signs of severe infection …

Non-albicans Candida (NAC) species cause 35–65% of all candidaemias in the general
patient population. They occur more frequently in cancer patients, mainly in those with …

We conducted population-based surveillance for Candida bloodstream infections in Spain to
determine its incidence, the extent of antifungal resistance, and risk factors for mortality. A …

Invasive fungal diseases (IFDs) are an increasingly common complication in critically ill
patients in Europe and are frequently fatal. Because of changes in treatment strategies and …

Candidemia studies have documented geographic differences in rates and epidemiology,
underscoring the need for surveillance to monitor trends. We conducted prospective …

Candida species are among the most common bloodstream pathogens in the United States,
where the emergence of azole-resistant Candida glabrata and Candida krusei are major …

We describe the annual incidence of primary bloodstream infection (BSI) associated with
Candida albicans and common non-albicans species of Candida among patients in …

In a surveillance study of candidemia in cancer patients that was conducted by the
European Organization for Research and Treatment of Cancer, 249 episodes were noted; …

Despite the widespread use of antifungals for prophylaxis, Candida bloodstream infection
(BSI) remains the most frequent life-threatening fungal disease. From an analysis of multi …